Showing results (51-60 of 457) with videos related to
Sort By:
Pageof 46
Annual Review of Pharmacology and Toxicology|January 1, 1994
Mechanisms of aflatoxin carcinogenesisD L Eaton, E P GallagherMammalian Genome : Official Journal of the International Mammalian Genome Society|April 6, 2017
Bridging the gap: large animal models in neurodegenerative researchS L Eaton, T M WishartThe Journal of Pharmacology and Experimental Therapeutics|September 1, 1978
Carrier-mediated transport of the organic cation procaine amide ethobromide by isolated rat liver parenchymal cellsD L Eaton, C D KlaassenCancer Treatment Reviews|June 6, 2003
Pathophysiology of bone metastases from prostate cancer and the role of bisphosphonates in treatmentColby L Eaton, R E ColemanToxicology and Applied Pharmacology|September 30, 1987
Comparative effects of butylated hydroxyanisole on hepatic in vivo DNA binding and in vitro biotransformation of aflatoxin B1 in the rat and mouseD H Monroe, D L EatonCancer Prevention Research (Philadelphia, Pa.)|June 18, 2014
Of mice, rats, and men: could Nrf2 activation protect against aflatoxin heptocarcinogenesis in humans?David L Eaton, Christopher M SchauppCurrent Opinion in Critical Care|August 29, 2023
Health system approaches to providing posthospital care for survivors of sepsis and critical illnessTammy L Eaton, Stephanie Parks TaylorToxicology and Applied Pharmacology|May 1, 1995
In vitro biotransformation of aflatoxin B1 (AFB1) in channel catfish liverE P Gallagher, D L EatonProceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|January 1, 1976
Effects of acute administration of taurocholic and taurochenodeoxycholic acid on biliary lipid excretion in the ratD L Eaton, C D KlaassenCancer Research|February 1, 1990
Species susceptibility to aflatoxin B1 carcinogenesis: comparative kinetics of microsomal biotransformationH S Ramsdell, D L EatonPageof 46